Lansing Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $473K | Sell |
10,227
-3,403
| -25% | -$158K | 0.14% | 93 |
|
2025
Q1 | $831K | Sell |
13,630
-757
| -5% | -$46.2K | 0.28% | 60 |
|
2024
Q4 | $814K | Sell |
14,387
-2,590
| -15% | -$146K | 0.28% | 50 |
|
2024
Q3 | $878K | Sell |
16,977
-505
| -3% | -$26.1K | 0.32% | 47 |
|
2024
Q2 | $726K | Buy |
17,482
+184
| +1% | +$7.64K | 0.3% | 55 |
|
2024
Q1 | $938K | Buy |
17,298
+8,595
| +99% | +$466K | 0.42% | 46 |
|
2023
Q4 | $447K | Buy |
+8,703
| New | +$447K | 0.23% | 59 |
|
2023
Q2 | $1.56M | Buy |
24,387
+1,398
| +6% | +$89.4K | 0.9% | 26 |
|
2023
Q1 | $1.59M | Sell |
22,989
-7,660
| -25% | -$531K | 1% | 25 |
|
2022
Q4 | $2.21M | Buy |
30,649
+1,568
| +5% | +$113K | 1.51% | 18 |
|
2022
Q3 | $2.07M | Buy |
29,081
+1,210
| +4% | +$86K | 1.6% | 18 |
|
2022
Q2 | $2.15M | Buy |
27,871
+134
| +0.5% | +$10.3K | 1.67% | 16 |
|
2022
Q1 | $2.16M | Buy |
+27,737
| New | +$2.16M | 1.37% | 22 |
|